http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108299256-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_217f2be73fd6be0be36dd55803d3bec5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-29
filingDate 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b68b59f6fdfa58d4a764fba5fa7287
publicationDate 2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108299256-A
titleOfInvention A class of 2,3,4-trihydroxybenzenesulfonamide derivatives and its preparation method and application
abstract The invention discloses a class of 2,3,4-trihydroxybenzenesulfonamide derivatives, a preparation method and application thereof, and its specific structural formula is shown in formula (I). Most of the 2,3,4-trihydroxybenzenesulfonamide derivatives in formula (I) exhibit good anti-interleukin IL-17A activity. IL-17A is not only related to autoimmune diseases, but also related to the occurrence and development of cancer. Based on this, the above-mentioned 2,3,4-trihydroxybenzenesulfonamide derivatives can be used to prepare immunomodulatory drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021027724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021027729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021027721-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341440-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341441-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341441-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341439-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341439-A
priorityDate 2018-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015187827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102199148-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3522264-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155808944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467307044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465769616

Total number of triples: 32.